Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis
about
Molecular Portrait of the Normal Human Breast Tissue and Its Influence on Breast CarcinogenesisWNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transitionIdentification of Biomarkers for Breast Cancer Using Databases.Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cellsDACH1 suppresses breast cancer as a negative regulator of CD44.Computational analysis of the mesenchymal signature landscape in gliomas.CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer.Expression profile of SIX family members correlates with clinic-pathological features and prognosis of breast cancer: A systematic review and meta-analysis.Are breast cancer stem cells the key to resolving clinical issues in breast cancer therapy?Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy.Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles.The Mesenchymal State Predicts Poor Disease-Free Survival in Resectable Non-Small Cell Lung Cancer.Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+/EpCAM+ phenotype: a promising target for preventing progression of TNBC.Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer.The prognostic value and clinicopathological significance of CD44 expression in ovarian cancer: a meta-analysis.CD44 promotes cell proliferation in non-small cell lung cancer.Combined overexpression of cadherin 6, cadherin 11 and cluster of differentiation 44 is associated with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
P2860
Q26744296-266F6AF8-069C-4148-8123-2BF73E1065A0Q28595799-7B68430F-BE08-448E-8675-F4094C48C9A1Q30239810-6CFAD6D0-3C9E-4DFE-A1F2-4C74A700ABE2Q33649240-7C0DCF6A-889A-4DD9-8794-ABA5E9D997E4Q33849252-693A419F-B9DE-4970-91F2-24AC5634EFF5Q36303247-400EFEE4-B77B-40A7-97A9-260B0A9BF858Q37252696-ACB75671-B87B-4BB8-BECF-CF034285D64CQ37328021-BD9A3FAA-D382-4DB4-BA46-D4B3A5319A74Q37626928-99966656-058D-4585-AB5C-0F2574BBF771Q38778198-7B56CA2C-9CC5-45CD-8727-08DFEFAA4CA6Q39113994-CAFEC7A9-2D7C-4FB0-9EEB-EC47614FFA06Q40203362-47B06653-4E77-427E-B142-6ABABBDA0919Q41611344-AE05F661-FA30-4089-A0D9-E63FD6004543Q50138615-90171545-90ED-4B6B-ABA0-DBC8DA06A66CQ51703765-7600B4D1-0BBA-4C00-9E1F-09918458B877Q53177018-5E8BEF7D-DFDD-41CA-B0A6-2C92087F751DQ55045647-B248F60F-8BB1-467C-998C-C2A6B15EC91F
P2860
Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Enrichment of CD44 in basal-ty ...... ll gene profile, and prognosis
@ast
Enrichment of CD44 in basal-ty ...... ll gene profile, and prognosis
@en
type
label
Enrichment of CD44 in basal-ty ...... ll gene profile, and prognosis
@ast
Enrichment of CD44 in basal-ty ...... ll gene profile, and prognosis
@en
prefLabel
Enrichment of CD44 in basal-ty ...... ll gene profile, and prognosis
@ast
Enrichment of CD44 in basal-ty ...... ll gene profile, and prognosis
@en
P2093
P2860
P356
P1476
Enrichment of CD44 in basal-ty ...... ll gene profile, and prognosis
@en
P2093
Gen Sheng Wu
Hanxiao Xu
Kongming Wu
Yijun Tian
P2860
P304
P356
10.2147/OTT.S97192
P407
P577
2016-01-21T00:00:00Z